Cite
Andermann TM, Fouladi F, Tamburini FB, et al. A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial. Transplant Cell Ther. 2021;27(11):932.e1-932.e11doi: 10.1016/j.jtct.2021.07.009.
Andermann, T. M., Fouladi, F., Tamburini, F. B., Sahaf, B., Tkachenko, E., Greene, C., Buckley, M. T., Brooks, E. F., Hedlin, H., Arai, S., Mackall, C. L., Miklos, D., Negrin, R. S., Fodor, A. A., Rezvani, A. R., & Bhatt, A. S. (2021). A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial. Transplantation and cellular therapy, 27(11), 932.e1-932.e11. https://doi.org/10.1016/j.jtct.2021.07.009
Andermann, Tessa M, et al. "A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial." Transplantation and cellular therapy vol. 27,11 (2021): 932.e1-932.e11. doi: https://doi.org/10.1016/j.jtct.2021.07.009
Andermann TM, Fouladi F, Tamburini FB, Sahaf B, Tkachenko E, Greene C, Buckley MT, Brooks EF, Hedlin H, Arai S, Mackall CL, Miklos D, Negrin RS, Fodor AA, Rezvani AR, Bhatt AS. A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial. Transplant Cell Ther. 2021 Nov;27(11):932.e1-932.e11. doi: 10.1016/j.jtct.2021.07.009. Epub 2021 Jul 16. PMID: 34274493; PMCID: PMC8556222.
Copy
Download .nbib